Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

09 CeoMeeting- Session2- Mascoma

770 views

Published on

Session 2: Industrial Biotechnology

Title: Replacing Fossil Fuels – How Do We Scale Up Without Compromising On Food And Environment?

Dr Jim Flatt, Mascoma

Published in: Technology, Business
  • Be the first to comment

  • Be the first to like this

09 CeoMeeting- Session2- Mascoma

  1. 1. Development and Commercialization of Consolidated BioProcessing for Cellulosic Biofuels Production MLSCF CEO Life Sciences Conference, 6 October 2009 Jim Flatt, Ph.D. Mascoma Corporation CONFIDENTIAL
  2. 2. Mascoma Background Team • Founded502 by Charlieyman & LeeLyndfrom DartmouthCollege, W world renownedleadersin cellulosicbiofuels research • Experienced industryleadershipteam • 70 + persontechnologyteam principallybasedin NH Consolidated Bioprocessing (CBP) Technology • Gamechanging “widely consideredto be the ultimate lowrcostconfigurationfor cellulose hydrolysisandfermentation” – DOE/SA JointResearch U Agenda • Enableslowrcostbiologicalconversionof cellulosicbiomassto a broadrangeof products • Lowcostandabundantfeedstock(currentlytargetinghardwoods) Facilities • CorporateOffice& Lab • Pilot & DemoPlant (Rome,NY) • Commercial acilityPlanned(inross, Michigan) F K • $49.5M in stateandfederal grants
  3. 3. Track Record of Securing Significant Private and Government Funding • Raised 0 $1 Million of equity • Strategicinvestmentsby industryrleadingpartners • Financial investmentsfrom toprtier venturecapital funds • Awardedover $60 million in FederalandState Confidential governmentfunding
  4. 4. Why Consolidated Bioprocessing? lower costs through enzyme reduction and process simplification Conventional Approach Mascoma Approach Feedstock Supply Steam & Power Generation Waste Treatment Mascoma Conditioning focus Enzyme Hydrolysis Supply Conditioning Fermentation Key Developing Distillation Technology & Storage
  5. 5. CBP Organism Development Strategy Goal Cellulose Utilization Ethanol Producer greenfield retrofit application application •C. thermocellum •T. saccharolyticum Yeast Substrate Strategy Metabolism Strategy Cellulose Utilization Commonalities X Cellulose Utilization X Ethanol Producer Ethanol Producer
  6. 6. Mascoma Recombinant Cellulolytic Yeast March,2007 to December, 2008: >3,000rfold improvement in expression levels
  7. 7. Enzyme Reductionon Hardwood Equivalent performance with 2.5 rfold less added enzyme Further reduction anticipated
  8. 8. Proof of Concept: CBP Yeast Ferments Paper Sludge to Ethanol with no added cellulase Positive Control 50 85% Appearance at 120 hrs. Yield 40 Ethanol Yield (g/L) CBP 30 20 10 CBP strain non-CBP Negative Control strain M1179 0 0 20 40 60 80 100 120 140 Fermentation Time (hours) 18% solids, 1 mg/gTS β
  9. 9. CBP Scalerup – Rome Demonstration Facility 60 50 Milestones Concentration (g/ l) 40 first E85 produced 11/08 30 CBP scale-up Q1.09 20 process engr. 2009 - 10 10 0 0 20 40 60 80 100 Age (h) 120 140 160 180 November 2008 Confidential
  10. 10. Promising Initial Results on Palm Residues Screening Test on Palm Residue Types • aqueous-based pretreatment • stem has highest yield • low lignin (17 – 18%) Palm Residue Carbohydrate Yield Max Ethanol Yield (% theoretical) (gal/mt) Empty Fruit Bunch 73 62 Stem 80 76 Frond 71 62
  11. 11. Mascoma Business Model • Diversify Feedstock – form funded collaborations to tailor Mascoma technology to other feedstocks e.g. paper sludge, palm residue and bagasse – equity participation for both parties • Diversify End products – form funded collaborations to adapt Mascoma technology to produce non-ethanol products • Commercial Rollout with Regional Partners – form JV with local partners – value capture for JV partner and Mascoma via equity – multiple plant focus – non-ethanol products
  12. 12. Conclusions – success hardwoodcanbe leveragedto other on cellulosicfeedstocks, includingpalmresidues

×